Synergistically, biochemical factors like ROS can stimulate and amplify IL-33 secretion in collaboration with the mycobiome.149 This IL-33 secretion may participate in triggering a type 2 immune response, hastening the pancreatic cancer progression along with reducing survival.152. This evidence concerns the gene IL33 and pancreatic neoplasm.